Advertisement
World

Scientists offer explanation for narcolepsy side effect of flu vaccine

Reading Time:1 minute
Why you can trust SCMP
The vaccine Pandemrix was pulled off the market amid reports of narcolepsy in Finland and elsewhere that sparked questions globally about flu shot safety. Photo: Reuters

One vaccine used in Europe during the 2009 swine flu pandemic was linked to rare cases of a baffling side effect - the sleep disorder narcolepsy. Now new research offers a clue to what happened.

The vaccine Pandemrix was pulled off the market amid reports of narcolepsy in Finland and elsewhere that sparked questions globally about flu shot safety.

On Wednesday, an international team of researchers reported the problem might have been a case of mistaken identity by the immune system.

Advertisement

Narcolepsy is an incurable disorder that interferes with normal sleep cycles, leaving people chronically sleepy during the daytime and apt to abruptly fall asleep. No one knows what causes it, although patients have very low levels of a brain chemical named hypocretin that's important for wakefulness.

Dr. Ivan Hung Fan-ngai, Clinical Assistant Professorof The University of Hong Kong shows a swine flu drug "H1N1 Convalescent Immunoglobulin IV". Photo: May Tse
Dr. Ivan Hung Fan-ngai, Clinical Assistant Professorof The University of Hong Kong shows a swine flu drug "H1N1 Convalescent Immunoglobulin IV". Photo: May Tse
In the new study, Dr Lawrence Steinman of Stanford University and colleagues found that the H1N1 virus contains a protein that is structurally similar to part of a brain cell receptor for that wakefulness chemical. They wondered if the flu-fighting antibodies generated by the Pandemrix vaccine might also latch onto those narcolepsy-linked receptors, leading to damage.
Advertisement

Colleagues in Finland sent blood samples that had been stored from 20 people diagnosed with vaccine-associated narcolepsy. Sure enough, 17 harboured antibodies capable of reacting both to flu and to those narcolepsy-linked receptors, Steinman's team reported in the journal Science Translational Medicine.

Advertisement
Select Voice
Choose your listening speed
Get through articles 2x faster
1.25x
250 WPM
Slow
Average
Fast
1.25x